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ABSTRACT
The NLRP3-inflammasome complex has emerged as an important component of 
inflammatory processes in metabolic dysfunction induced by high-caloric diets. In 
this study, we investigate the molecular mechanisms by which NLRP3 inhibition may 
attenuate diet-induced cardiac injury. Here we show the cardiac damage induced 
by high sugar diet (HSD), high fat diet (HFD) or high sugar/fat diet (HSFD) over 
15 weeks. Genetic ablation of NLRP3 protected against this damage by autophagy 
induction and apoptotic control. Furthermore, NLRP3 inhibition by the selective small 
molecule MCC950 resulted in similar autophagy induction and apoptotic control in 
hearts after diets. These data were reproduced in THP-1 cells treated with MCC950 and 
cultured in media supplemented with serum from mice dosed with MCC950 and fed 
with diets. NLRP3 inhibition exerted beneficial metabolic, and autophagic adaptations 
in hearts from obesogenic diets. The inhibition of NLRP3 activation may hold promise 
in the treatment of metabolic and cardiovascular diseases.
INTRODUCTION
Cardiovascular disease (CVD) is the leading 
cause of death in the world with a high prevalence both 
in industrialized but also in low- and middle-income 
countries [1]. Studies show that only about 8% US 
adults had a low risk profile for cardiovascular disease 
between 1999 and 2004 [2]. In Spain, the level of ideal 
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cardiovascular health is as low as in the United States 
[3]. Energy-rich diets high in fat, processed and refined 
carbohydrate foods, together with sedentary lifestyles have 
led to an increased CVD risk, and this effect is thought to 
be mediated primarily by elevated LDL cholesterol blood 
levels. In these cases, the role of obesity is especially 
relevant because multifactorial pathophysiological 
mechanisms interrelate this condition with other diseases 
such as type 2 diabetes, renal disease, and metabolic 
syndrome. All these obesity-induced complications share 
a low-grade systemic inflammatory response characterized 
by upregulated cytokine production and activated 
signaling pathways [4], yet the specific inflammation-
related signaling pathways contributing to the metabolic 
dysfunction are still unknown. On this respect, the 
NLRP3-inflammasome complex has been described as a 
‘danger sensor’, which triggers an innate immune response 
to a multitude of endogenous metabolic danger patterns 
inducing sterile inflammation [5]. NLRP3 activation 
induces the recruitment and autocatalytic activation of the 
cystein protease caspase-1, which processes the cytosolic 
precursors of the related cytokines IL-1β and IL-18, and 
leads to the secretion of the biologically active form of 
these cytokines [6].
Mice fed with HFD developed NLRP3-
inflammasome activation in adipose, renal and hepatic 
tissues [7–9]. Interestingly, the absence of NLRP3 in 
these animals protected them to the adverse effects of 
HFD and the development of pathophysiology [7–9]. 
However, the role of NLRP3 in the pathogenesis of HFD-
induced CVD appearance has not been characterized. 
Recent observations identified a specific role for NLRP3-
inflammasome in the maladaptive response in cardiac 
tissue after ischemia/reperfusion in mice under high-fat 
high-fructose diets [10] and in the diabetic cardiomyopathy 
obseved after HFD and streptozotocin treatment in rats 
[11]. To understand the role of the NLRP3-inflammasome 
in diet induced-cardiac damage, we assesed the response 
of NLRP3 -/- mice, and the effect of the NLRP3 inhibitor 
MCC950 on high sugar diet (HSD), HFD and high sugar/
fat diet (HSFD).
RESULTS
Absence of the NLRP3 protects from HSD, HFD 
and HSFD-induced obesity
We have investigated the role of the NLRP3-
inflammasome in mice lacking the NLRP3 gene and 
exposed to the different diets inducing obesity. Food 
intake and bodyweight evolution were examined weekly 
during 15 weeks in each group. The different diets have 
been shown to induce significant weight gain in WT 
mice (Figures 1A and 1B) [7] despite increased food 
consumption that was similar in all WT and NLRP3-
/- mice groups (Figures 1C and 1D). Predictably, hearts 
from WT mice were substantially heavier than SD-fed 
animals at the end of the study (p<0.05) (Figure 1E and 
Supplementary Figure 1). This finding was not altered in 
the NLRP3 -/- genotype on any obesity-associated diet.
In humans, high-caloric diets cause numerous 
alterations including increased glucose, cholesterol 
levels and leptin/adiponectin dysregulation leading to 
cardiovascular disease, metabolic syndrome, and non-
alcoholic fatty liver disease [12, 13]. The HSD, HFD 
and HSFD-fed WT mice showed increased serum levels 
of leptin (HSD and HFD, p<0.05; HSFD, p<0.001) and 
leptin/adiponectin ratio (p<0.001) (Figures 1F-1H), 
including abnormal serum levels of glucose, cholesterol, 
triglycerides, hepatic transaminases, uric acid and 
creatinine (Supplementary Table 2). These changes were 
not observed in NLRP3 -/- mice.
NLRP3-deficiency induce a moderate 
protection against oxidative stress in heart and 
inflammation
Oxidative stress has an essential role in 
inflammasome activation [14], and has been implicated in 
the cardiac pathophysiology induced by obesogenic diets 
[15]. Accordingly, analysis of oxidative stress biomarkers 
in hearts of HSD, HFD and HSFD fed WT mice revealed 
significant increases in lipid peroxidation (Figure 2A), 
protein carbonyls (Figure 2B) and of 8-oxoguanine 
glycosylase (OGG1) (Figures 2C and 2D). Compared 
to WT mice, NLRP3 -/- mice had a trend toward an 
elevated lipid peroxidation and OGG-1 levels (Figures 
2A-2D). This finding was consistent with the antioxidant 
biomarkers were not increased in these knockout animals 
challenged with obesogenic diets, suggesting perhaps the 
absence of compensatory defense mechanisms (Figures 
2E and 2F) in this genotype. These results were also 
accompanied by elevated serum inflammatory biomarkers 
such as IL-1β and TNF-α in WT mice (Figures 2G and 
2H). Interestingly, no differences in serum levels of IL-1β 
and a moderate increase in TNF-α were observed in all 
NLRP3 -/- groups (Figures 2G and 2H).
Because high fat diet is also associated to 
cardiomyocite apoptosis, which is coupled with oxidative 
stress and inflammation dysregulation [16], we determined 
several apoptotic biomarkers. Here HSD, HFD and 
HSFD feeding resulted in a significant increase in 
protein expression of cardiac BAX and active caspase 3 
(Figures 3A, 3B and 3G) accompanied by reduced cardiac 
expression levels of antiapoptotic protein Bcl-2 (Figures 
3C and 3G) in WT mice. NLRP3 -/- mice showed reduced 
contents of apoptosis-related markers, consistent with 
the accumulation of Bcl-2 which stimulates antiapoptotic 
activity in heart (Figures 3C and 3G). Interestingly, these 
observations were also accompanied by increased SIRT1 
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Figure 1: Nlrp3 signaling suppression prevents obesity induced effects of the HSD, HFD and HSFD diets.  (A and B) 
Body weight chart of diets-induced obesity in WT and NLRP3 -/- mice. The mice were fed with the diets for 15 weeks and their body 
weights were monitored weekly. (C and D) Average daily oral food intake normalized to body weight, measured on the different diets. The 
food intake of mice was measured was monitored weekly. (E) Heart weight normalized to body weight. (F-H) Levels of leptin, adiponectin, 
and ratio in plasma. Blood samples were collected after overnight fasting. All data are presented as means ± SEM, n = 10 mice; *P < 0.05, 
*P < 0.005, ***P < 0.001.
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Figure 2: Nlrp3 signaling elimination protects against oxidative and inflammatory effects of the HSD, HFD and 
HSFD diets.  (A and B) Levels of lipid peroxidation, and protein carbonyls in heart tissues from mice. (C) Protein expression level of 
8-oxoguanine glycosylase (OGG-1), MnSOD and catalase. (D-F) Densitometric quantification of protein expression levels of western blots 
in heart tissues from mice relative to GAPDH (loading control). All data are presented as means ± SEM with a representative blot, n = 6–10 
mice. (G and H) IL-1β and TNF-α levels in serum from WT and NLRP3 -/- mice fed with the differents diets were determined by ELISA. 
All data are presented as means ± SEM with a representative blot, n = 10 mice; *P < 0.05, ***P < 0.001 HSD, HFD and HSFD vs SD; aP < 
0.005 WT vs NLRP3 -/-.
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Figure 3: Changes in apoptosis and autophagy in response to HSD, HFD and HSFD diets in WT and NLRP3 -/- mice. 
(A-C) Densitometric quantification of protein expression levels of Bax, Caspase 3 and Bcl-2 in heart tissues from mice relative 
to GAPDH (loading control). (D) Densitometric quantification of protein expression levels of Sirt1 in heart from mice. (E-F) 
Densitometric quantification of protein expression levels of autophagy markers in the heart. (G) Western blot analysis with 
representative blot including LC3. (H and I) Expression levels of Parkin and p62 level in the hearts of WT and NLRP3 -/- 
mice. All data are presented as means ± SEM, n =6–8 mice; *P < 0.05, **P < 0.005, ***P < 0.001 HSD, HFD and HSFD vs SD; 
aP < 0.005 WT vs NLRP3 -/-.
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protein expression levels in knockout mice (Figures 3D 
and 3G) which has a role in heart protection, for example, 
by anti-inflammatory and antioxidant effects [16].
NLRP3-deficient mice show an autophagic 
protection against HSD, HFD and HSFD-
Induced heart damage
One of the most important mechanisms in the 
cardiac protection/injury is autophagy, which is impaired 
during aging and diet-induced obesity, producing a less 
effective clearance process and contributing to important 
cardiac damage [17]. HSD, HFD and HSFD induced 
high expressions of two important autophagic proteins 
such as Beclin 1 and ATG-12 (Figures 3E, 3F and 3G) 
in WT animals. Furthermore, we observed an impaired 
autophagic flux determined by expression of LC3-II and 
increased expression of proteins involved in clearance 
pathways such as PARKIN and p62/SQSTM1 (Figures 
3G, 3H and 3I). Interestingly, all NLRP3 -/- groups 
showed an increased and more efficient autophagic 
machinery (Figures 3E-3I). As LC3-II overexpression can 
evoke either an increment of autophagy or an impairment 
of the autophagic flux, these LC3-II changes must to 
be interpreted together with the p62/SQSTM1 levels 
and minding that LC3-II itself is subject to autophagic 
degradation at the lysosome [18]. As, NLRP3 -/- mice 
showed a more efficient autophagy induction, as the 
lower levels of LC3-II (Figure 3G) and the reduced levels 
of proteins such as parkin (Figure 3H) and p62/SQSTM1 
(Figure 3I) is suggesting.
Changes in gene expression of adhesion 
molecules and fibrosis markers in heart
To assess the impact of the diets on myocardial 
histology, cardiomyocyte cross-sectional area and 
fibrosis were examined. In the hematoxylin-and-eosin–
stained sections, HSD and HFD but not HSFD showed a 
disarrangement of myofibrils and increased cardiomyocyte 
transverse cross-sectional area. However, NLRP3 
-/- groups only showed a moderate increase in HFD 
(Figures 4A, 4B and Supplementary Figure 2). Further 
examination with Masson trichrome staining revealed 
overt perivascular fibrosis after diets in WT group without 
significant changes in NLRP3 -/- group (Figure 4A and 
Supplementary Figure 2). We also studied the changes 
in gene expression of several biomarkers of endothelial 
activation and fibrosis. Intercellular adhesion molecule 
1 (ICAM-1) and vascular cell adhesion molecule 1 
(VCAM-1) were increased in heart tissues of HSD, HFD 
and HSFD-fed animals, but no significant changes were 
observed in NLRP3 -/- animals exposed to the same diets 
(Figure 4D). Similarly, typical fibrosis biomarkers such 
as Matrix metallopeptidase 2 (MMP2) and fibronectin, 
were also increased in heart tissues of HSD, HFD and 
HSFD-fed WT animals but again, nonoteworthy changes 
were observed in NLRP3 -/- mice (Figure 4D). In the 
same line, apoptosis biomarker caspase 3 and endotelial 
inflammatory biomarker COX-2 were also increased in 
heart tissues of HSD, HFD and HSFD-fed animals but 
again, whilst no significative changes were observed in 
knockout animals (Figure 4D).
Pharmacological inhibition of NLRP3 prevent of 
the HSD, HFD and HSFD-Induced obesity and 
heart damage
Using a pharmacological approximation, we have 
tested the effect of the same diets after inhibition of 
NLRP3 with MCC950. WT groups for this experiment 
were distributed in vehicle and the different diet+MCC950 
(20 mg/Kg/day i.p.) animals. After fifteen weeks, all 
obesogenic diets led to increased weight in the vehicle 
group (Figure 5A), however the pharmacological 
inhibition of NLRP3- protected these animals from obesity 
(Figure 5A), similar to the genetic NLRP3 deletion. 
The daily food intake was lower in MCC950-treated 
groups compared to vehicle groups but, interestingly, 
with comparable relative changes among the different 
diets (Figure 5B). The different diets were shown to 
increase the heart weight in vehicle groups (Figure 5C 
and Supplementary Figure 3), with no change after 
MCC950 administration. Furthermore, MCC950 reduced 
cardiomyocytes area and perivascular fibrosis induced by 
diets (Supplementary Figure 4).
The metabolic studies performed with these groups 
of animal showed how the treatment with the MCC950 
inhibitor ameliorated the effect on several circulating 
metabolites. Thus, the increased leptin and leptin/
adiponectin ratio observed after HSD, HFD and HSFD 
feeding in vehicle groups, was reduced in the MCC950-
treated groups with elevated adiponectin levels (Figures 
5D-5F). Similarly, some alterations of biomarker levels in 
serum including glucose, cholesterol, triglycerides, hepatic 
transaminases, uric acid and creatinine (Supplementary 
Table 3) were reverted in the MCC950-treated mice.
Guided by these findings on several metabolic 
pathways, we examined the effect of the obesogenic diets 
on oxidative stress, apoptosis and autophagy in heart 
tissues and compared to the observations described with 
NLRP -/- mice. As expected, we observed that the inhibitor 
resulted in a significant reduction of lipid peroxidation 
compared to those in the HSD, HFD and HSFD-vehicle 
groups together with a reduction of MnSOD protein 
expression (Figures 6A-6C). Additionally, MCC950 also 
induced down-regulation of the active caspase 3 apoptotic 
protein (Figures 6B and 6D).
We also observed the same protective mechanisms 
in cardiac tissues determined by the high overexpression 
levels of SIRT1 in heart tissues of MCC950 treated 
groups (Figures 6B and 6E). Consistent with the NLRP3 
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Figure 4: Histological analyses and gene expression changes of adhesion molecules and fibrosis markers in heart.  
(A) Representative hematoxylin-and-eosin–stained micrographs showing transverse sections of Left Ventricular (LV) myocardium, cross-
sectional area and representative Masson trichrome–stained micrographs showing perivascular sections of myocardium of HFD from WT 
and NLRP3 -/-. Complete diets see Supplementary figure 2. (B) Quantitative analysis of cardiomyocyte cross-sectional (transverse) area 
with measurements of ≈100 cardiomyocytes from 3 to 6 mice per group. *P < 0.05, **P < 0.005, ***P < 0.001 HSD, HFD and HSFD vs SD. 
(C) Relative gene expressions of ICAM-1 and VCAM-1 (mean±SEM) determined by quantitative PCR in heart from WT and NLRP3 -/-. 
Relative gene expressions of MMP-2, and fibronectyn and relative gene expressions of Caspase 3 and COX-2 determined by quantitative 
PCR in heart from WT and NLRP3 -/-. All data are presented as means ± SEM, n =6 mice; *P < 0.05, **P < 0.005, ***P < 0.001 HSD, HFD 
and HSFD vs SD.
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Figure 5: NLRP3 inhibition by MCC950 prevents obesity induced effects of the HSD, HFD and HSFD diets.  (A) Body 
weight chart of diets-induced obesity in WT-vehicle and MCC950 mice fed with HSD, HFD and HSFD diets. The mice were fed with the 
diets for 15 weeks and their body weights were monitored weekly. We represent the changes of the final week respect to the first week. 
(B) Average daily oral food intake normalized to body weight, measured on the different diets. The food intake of mice was measured was 
monitored weekly. We represent the changes of the final week respect to the first week. (C) Heart weight normalized to body weight. (D-F) 
Levels of leptin, adiponectin, and ratio in plasma. Blood samples were collected after overnight fasting. All data are presented as means ± 
SEM, n = 10 mice; *P < 0.05, ***P < 0.005 HSD, HFD and HSFD vs SD; aP < 0.05, aaP < 0.005 MCC950 vs vehicle.
Oncotarget99748www.impactjournals.com/oncotarget
Figure 6: Changes in oxidative stress, apoptosis and autophagy in response to MCC950.  (A) Lipid peroxidations. (B) 
Protein expression levels by western blot of MnSOD antioxidants in heart after MCC950 treatment in mice. We compare HSD, HFD and 
HSFD diets with MCC950 treated groups. (C) Densitometric quantification of protein expression levels of the antioxidant in heart tissues 
from mice relative to GAPDH (loading control). (D) Densitometric quantification of protein expression levels of the active Caspase 3 
protein. (E) Densitometric quantification of protein expression levels of Sirt1 in heart from mice. (F and G) Densitometric quantification 
of protein expression levels of autophagy markers ATG12 and p62 in the heart in the hearts after diets and MCC950 treatment. All data are 
presented as means ± SEM with a representative blot, n= 4–5 mice; *P < 0.05, ***P < 0.001 MCC950 vs vehicle.
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-/- protective phenotype, we observed an increase of 
ATG12 and LC3II protein expression after diets with a 
p62/SQSTM1 accumulation, which were restored after 
treatment with MCC950 (Figures 6B, 6F and 6G). This 
autophagy induction was also demonstrated in an in vitro 
experiment. THP-1 cells treated with this inhibitor showed 
similar induction of autophagy as with rapamycin with 
an improved autophagic flux (Supplementary Figure 5). 
MCC950 also reduced serum biomarkers of inflammation 
such as IL-1β and TNF-α associated with the different 
diets (Supplementary Figure 6).
Serum from HSD, HFD and HSFD-fed mice 
induce inflammasome and inflammation 
activation in monocytes
It is known that some soluble circulating factors can 
induce cardiac damage and systemic inflammation [19]. 
We next sought to investigate if serum separated from 
these mice are able to induce these alterations in cultured 
cells. Since the diets induced increased released levels of 
IL-1β and TNF-α in serum, an inflammatory phenotype 
could be induced in cells. THP-1 monocytes were 
incubated for 24 hr with media containing serum from 
mice fed with either SD, HSD, HFS, and HSFD diets for 
15 weeks and the inflammatory profiles were determined. 
Our results indicate that incubation with these sera show 
an increase in inflammasome gene expression NLRP3 
(p<0.01) and IL-1β (p<0.01) (Figure 7A and 7B) and other 
inflammatory genes such as TNF-α (p<0.01) and IL-6 
(p<0.01) (Figures 7C and 7D, which were accompanied 
by IL-1β and TNF-α medium release (Figures 7E and 
7F). Interestingly, the incubation with media containing 
different sera from mice fed with SD, HSD, HFS, and 
HSFD diets and treated with MCC950 showed a reduction 
in inflammasome (p<0.01) (Figures 8A and 8B) and other 
inflammatory genes expression (p<0.01) (Figures 8C 
and 8D). This may be due to the high protein binding of 
MCC950 (a sulfonyl urea), which results in a significant 
amount of drug in serum, being available for release in the 
in vitro assay.
DISCUSSION
It has been shown that chronic over-nutrition: 
i) can induce inflammasome activation in several 
metabolic tissues such as adipose, renal and hepatic 
tissues [7–9], ii) can activate the NLRP3-inflammasome 
in macrophages [20], iii) has been involved in obesity-
induced inflammation and insulin resistance [21], and 
iv) can initiate intestinal inflammation in epithelial cells 
[22]. In this context, activation of NLRP3 inflammasome 
mediating IL-1β and IL-18 secretion has emerged as 
an important component of inflammatory processes in 
cardiovascular diseases [23, 24]. Our findings provide 
interesting data of how these obesogenic diets promote 
the activation of NLRP3-inflammasome in the heart. 
The HSD, HFD and HSFD feeding induced not only an 
important increment in body and heart weights, but also 
an increment in several important cardiovascular risk 
biomarkers such as high levels of leptin and leption/
adiponectin ratio [25] as well as alterations in several 
biochemical parameters and tissue damage biomarkers. 
These diets also induced cardiac damage by increased 
oxidative stress, inflammation, apoptosis and an impaired 
autophagy process. Corroborating existing literature, 
all these physical and metabolic alterations have been 
observed in HFD and HSD, and both have been closely 
linked to an increased obesityrisk, cardiac disease, 
diabetes (T2D), metabolic syndrome, non-alcoholic fatty 
liver disease [26].
Autophagy is a critical mechanism to preserve 
cellular homeostasis and has been implicated in the 
maintenance of cardiac structure and function under 
physiological and/or pathological conditions. Different 
studies have demonstrated an indispensable role of 
this process in the etiology of cardiac anomalies under 
obesity and metabolic syndrome [27]. In fact, obesity 
induced by HFD showed an impairedautophagic flux 
in heart tissue [28] similar to our observations. A high-
carbohydrate (fructose) has also been shown to induce 
the same modifications in hepatic tissues [29], which 
could corroborate our observations in heart induced by 
all high caloric diets. Obesity is recognized as a chronic, 
low-grade, systemic inflammation, which contributes to 
the development of several metabolic and cardiovascular 
diseases [4]. The fact that these observed effects were 
partially reproduced in THP-1 monocytes incubated with 
media supplemented with serum from mice fed HSD, 
HFS or HSFD suggest systemic effects of high glucose, 
cholesterol or other serum factors with potential interest 
to the development of these metabolic and inflammatory 
adaptation, and autophagic impairment.
The role of NLRP3-inflammasome in the HFD-
induced and obesity-related cardiovascular disease has 
been poorly studied. However, NLRP3 in subcutaneous 
adipose tissue has been associated with the severity 
of coronary atherosclerosis [30]. A recent study has 
shown genetic variants of NLRP3 in the pathogenesis 
of atherosclerosis [31], and NLRP3 and inflammatory 
cytokines have also been proposed as new cardiovascular 
risk biomarkers [32]. Taken together, these data suggest 
that the inhibition of inflammasome complex could 
help to protect the progression of many metabolic and 
cardiovascular diseases. Our results demonstrate that 
the NLRP3 deficient mice are protected from HSD, 
HFD and HSFD-associated body-weight gain, left 
ventricle hypertrophy and increased myocardial mass 
and related cardiomyopathies, and the disappearance of 
different cardiac remodeling-related dysfunctions and the 
absence of alterations in key biochemical biomarkers. 
All these observations are in concordance with previous 
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Figure 7: Pro-inflammasome and pro-inflammation effects in THP-1 monocytes cultivated with different sera from 
WT mice fed with HSD, HFD and HSFD diets.  (A and B) Relative gene expression of NRLP3 and IL-1β determined by quantitative 
PCR in THP-1 cells. (C and D) Relative gene expression of TNF-α and IL-6 determined by quantitative PCR in THP-1 cells. (E and F) 
IL-1β and TNF-α medium release from THP-1 cells. THP-1 monocytes was assessed after a 24 hr incubation with media containing serum 
from mice fed with SD, HSD, HFS, and HSFD diets for 15 weeks. The graphs show the mean ± SEM from three independent experiments. 
***P < 0.01.
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observations on the protective effect of inflammasome 
complex in mice and reducing HFD pathological effects 
[7-9, 20, 21]. However, similarly to previous studies [7, 
33], increased leptin levels in NLRP3 deficient mice was 
similar to WT mice on HSD and HFD, whereas NLRP3 
knockout mice did not show changes in cardioprotective 
adiponectin levels [34]. NLRP3 deletion also showed a 
moderate but not significant oxidative stress increase, 
which was not enough to induce antioxidants synthesis 
in these animals. These results were accompanied 
by increased levels of pro-inflammatory TNF-alpha 
but not the IL-1β in WT animals in obesogenic diets. 
However, NLRP3 -/- mice showed attenuated increases 
in pro-inflammatory mediators, strengthening the idea 
that these knockout animals are more protected from 
damages induced by these diets. These observations were 
accompanied by reduced apoptosis induction in NLRP3 
-/- mice with increased expression of the anti-apoptotic 
Bcl-2 and Sirt1, a NAD+-dependent class III histone 
deacetylase, which has been shown to protect from 
endothelial dysfunction, atherothrombosis, diet-induced 
obesity, type 2 diabetes, liver steatosis, and myocardial 
infarction [35]. In this sense, NLRP3 -/- mice showed no 
modifications in gene expression of potential vascular 
dysfunction and regulators of fibrosis induced in heart 
tissues by the diets. Interestingly, very recent and elegant 
studies have shown that mice deficient in inflammasome 
components are resistant to endothelial dysfunction and 
Figure 8: Inflammasome inhibition in THP-1 monocytes cultivated with sera from MCC950-treated WT mice fed with 
HSD, HFD and HSFD diets. (A and B) Relative gene expression of NRLP3 and IL-1β determined by quantitative PCR in THP-1 cells. 
(C and D) Relative gene expression of TNF-α and IL-6 determined by quantitative PCR in THP-1 cells. THP-1 monocytes were assessed 
after a 24 hr incubation with media containing serum from mice fed with SD, HSD, HFS, and HSFD diets and mice fed with SD, HSD, 
HFS, and HSFD and treated with MCC950 for 15 weeks. The graphs show the mean ± SEM from three independent experiments. *P < 0.05, 
*P < 0.005, ***P < 0.001.
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fibrosis induced by different challenges in liver, lung or 
kidney, similar to our observations in the heart [36–38]. In 
mammalian cells, Sirt1 modulate distinct metabolic and 
stress-response pathways including autophagy [39] so, the 
increased expression of this protein in NLRP3 -/- mice 
could improve the capacity for metabolic adaptation and/
or cardiovascular protection. Likewise, NLRP3 -/- mice 
showed a very efficient autophagy flux. Collectively, all 
these studies and the recent findings that these mice have 
also efficient autophagy flux in lung tissues and improved 
resistance to hyperoxia [40] indicate that NLRP3 
deficiency remarkably protect different organs from stress 
situations, such as the obesogenic diets.
Further, the inhibition of inflammasome activation 
recently been shown to induce an important protective 
effect in cardiac injury. Abderrazak et al., (2016) 
showed an inbihition of NLRP3-inflammasome and 
autophagy induction in ApoE2. Ki mice in high-fat diet 
after treatment with a natural product called arglabin 
[41]. Other novel inhibitor named as 16673-34-0, an 
intermediate substrate of the synthesis of glyburide free 
of the cyclohexylurea moiety, has a potent inhibitory 
effect limiting the secondary inflammatory response 
and reducing infarct size in a mouse model of acute 
myocardial ischemia-reperfusion injury [42]. More 
recently, MCC950 has been shown to reduce the infarct 
size and preserves cardiac function in a randomized, 
blinded translational large animal myocardial infarction 
model [43]. In our study, we have studied for the first time 
the protective effect of the same selective inhibitor, on 
cardiac tissues induced by obesogenic diets. We showed 
that daily intraperitoneal administration of MCC950 
prevent from HSD, HFD and HSFD-associated body-
weight gain, heart-weight gain, increased circulating 
adiponectin, and maintained leptin and leptin/adiponectin 
levels, in line with this protection role. Our study also 
reveals that other circulating markers of tissue damage 
and inflammation were reduced in animals treated with 
MCC950. Furthermore, results in MCC950 treated mice 
reproduced previous observations with NLRP3 -/- mice 
under oxidative stress displayedreduced apoptosis and 
induced Sirt1 expression accompanied by an improved 
autophagy flux in heart tissues. Finally, previous in vitro 
studies have shown a reduction of inflammation in cells 
treated with serum from HFD+Resveratrol fed animals 
because of anti-inflammatory effect and overexpression 
of Sirt1 induced by this compound [13, 44]. In line 
with these studies, we observed that THP-1 monocytes 
treated with media supplemented with serum from mice 
fed with HSD, HFD or HSFD+MCC950 diets had lower 
mRNA expression of the inflammasome (NLRP3 and 
IL-1β) and inflammation (TNF-α and IL-6) components 
when compared to the chronic overfeeding animals. 
Taken together, these data indicate that monocytes could 
contribute, at least in part, to the beneficial effects of 
MCC950 in systemic inflammation.
In conclusion, our data suggests that the inhibition 
of NLRP3-inflammasome produces beneficial metabolic, 
inflammatory and could induce an autophagic adaptations 
in the heart of diet-induced obesity mice models. In 
addition, it is possible that monocytes could participate in 
the heart damage induced by systemic inflammation after 
chronic exposure to unhealthy diets. Although lifestyle 
changes are the primary interventions to prevent obesity 
and consequent heart failures associated to obesogenic 
diets, the damages occasioned in cardiac tissues after 
prolonged unhealthy habits can be irreversible. In these 
cases, the use of inflammasome inhibitors such as 
MCC950, with a potential autophagic adaptation of the 
tissues, may hold a promise as therapy to ameliorate heart 
damage and metabolic changes, which accelerates CVD.
MATERIALS AND METHODS
Ethical statements
Animal studies were performed in accordance 
with the European Union guidelines (2010/63/EU) and 
the corresponding Spanish regulations for the use of 
laboratory animals in chronic experiments (RD 53/2013 on 
the care of experimental animals). All experiments were 
approved by the local institutional animal care committee.
Animals
For all experiments, only male mice were used. C57/
BL6/J mice and NLRP3−/− transgenic mice (C57BL/6J 
background), weighing 25-30 g were maintained on a 
regular 12 h light/dark cycle. Diets were started at 16 
weeks of age after randomization into four groups. These 
groups correspond to the following dietary regimens: 
i) regular chow or standard diet (SD) from Teklad 
Global 14% Protein Rodent Maintenance Diet, Harlan 
Laboratories (carbohydrate:protein:fat ratio of 48:14:4 
percent of kcal); ii) a HFD consisting of Teklad Global 
modified to provide 45% of calories from fat; iii) a 
high sugar diet consisting of Teklad Global modified to 
provide 32% of calories from sucrose and a HSFD with 
the combination of fat and sucrose. MCC950 was included 
in different groups with the same diets in daily doses of 20 
mg/kg (drug/kg body weight). All groups had ad libitum 
access to their prescribed diet and water throughout the 
study. Body weight and food intake were monitored 
weekly. Animal rooms were maintained at 20–22°C with 
30–70% relative.
Reagents
Monoclonal antibodies specific for Beclin-1 and 
p62 were purchased from Sigma-Aldrich (Saint Louis, 
USA). Anti-GAPDH monoclonal antibody was acquired 
from Calbiochem-Merck Chemicals Ltd. (Nottingham, 
UK). Similarly, anti-NLRP3 antibody was purchased from 
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Adipogen (San Diego, USA); while anti-active caspase-3, 
anti-SIRT-1 and anti-Parkin were obtained from Cell 
Signalling Technology (Beverly, MA, USA). Finally, 
anti-IL-1β (p17), anti-OGG-1, anti-Bcl-2, anti-Bax, anti-
MnSOD, anti-catalase, anti-ATG12 and anti-MAP-LC3 
antibodies from (Santa Cruz Biotechnology). A cocktail 
of protease inhibitors (Complete™ Protease Inhibitor 
Cocktail) was purchased from Boehringer Mannheim 
(Indianapolis, IN). The Immun Star HRP substrate kit was 
obtained from Bio-Rad Laboratories Inc. (Hercules, CA).
In vitro cell experiments
THP-1 cells, a human leukemia monocytic cell 
line extensively used to study monocyte/macrophage 
functions, were cultured at 37ºC in a 5% CO2 atmosphere 
in RPMI-1640 medium supplemented with L-glutamine, 
an antibiotic/antimycotic solution (Sigma Chemical Co., 
St. Louis, MO, USA), and 10% fetal bovine serum. THP-
1 cells were incubated for 24 hr with media containing 
serum from mice under SD, HSD, HFD and HSFD diets.
IL-1β and TNF-α levels
Serum or culture medium levels of IL-1β (GenWay, 
San Diego CA, USA) and TNF-α (Biosource, UK, and 
GenWay, San Diego, USA) were assayed in duplicate 
using commercial ELISA kits.
Leptin and adiponectin
Serum levels of leptin and adiponectin were assayed 
in duplicate using commercial ELISA kits (R&D Systems, 
Minneapolis, USA).
Serum biomarkers
Serum levels of glucose, triglycerides, cholesterol, 
uric acid, aspartate aminotransferase, alanine 
aminotransferase and creatine kinase were assayed using 
commercial kits (Randox Laboratories, Antrim, UK).
Immunoblotting
Western blotting was performed using standard 
methods. After protein transfer, the membrane was 
incubated with various primary antibodies diluted 1:1000, 
and then with the corresponding secondary antibody 
coupled to horseradish peroxidase at a 1:10000 dilution. 
Specific protein complexes were identified using the 
Immun Star HRP substrate kit (Biorad Laboratories Inc., 
Hercules, CA, USA).
Lipid hydroperoxides
The FOX assay was carried out according to the 
method previously reported [45]. The FOX reagent 
was prepared by mixing in the order: 90 ml methanol, 
88 mg BHT, 10 ml 250 mM H2SO4, 9.8 mg ammonium 
ferrous sulfate hexahydrate and 7.6 mg xylenol Orange. 
680 μl of FOX reagent were added to 320 μl of each 
sample, and the solution was incubated for 30 min at 
37 °C with gentle shaking. After a short high-speed 
centrifugation (3,000×g for 1 min at room temperature), 
samples absorbance was read at 560 nm against the blank 
(0.9% NaCl and FOX reagent). For hydroperoxides 
quantification, a serial standard dilution of hydrogen 
peroxide was used.
Protein carbonyl
Protein carbonyls were assayed in duplicates by 
commercial ELISA kits using a commercial kit from 
Cayman Chemical (Ann Arbor, Michigan, USA).
Histological study
After anesthesia of mice, hearts were excised and 
immediately placed in a 10% neutral-buffered formalin 
at room temperature for 24 hours after a brief rinse with 
PBS. The specimens were embedded in paraffin, cut in 
5-μm sections, and stained with hematoxylin and eosin. 
Cardiomyocyte cross-sectional areas were calculated on 
a digital microscope (×400) with ImageJ (version 1.34S) 
software. Masson’s trichrome staining was used to detect 
fibrosis in heart sections and fibrotic areas were also 
calculated on a digital microscope (×400) with ImageJ 
(version 1.34S) software.
Real-time quantitative PCR
The expression of NLRP3 gene was analyzed 
by SYBR Green quantitative PCR of mRNA extracted 
from cardiac tissues. Total cellular RNA was purified 
from the cells using the Trisure method (Bioline, 
London, UK). RNA concentration was determined 
spectrophotometrically. Contaminating genomic 
DNA was removed by incubation of one microgram 
of total RNA from each sample with gDNA wipeout 
buffer (Quantitect Reverse Transcription Kit, Qiagen. 
Hilden, Germany) for 5 min at 42°C. RNA samples 
were subsequently retrotranscribed to cDNA using the 
QuantiTect Reverse Transcription Kit (Qiagen. Hilden, 
Germany). Thermal cycling conditions used were 
denaturation at 95°C for 20 s, 40 cycles of priming 
at at 54°C for 20 s, and elongation at 72°C for 20 s. 
Primers used can be consulted in Supplementary Table 
1. All reactions were performed in duplicate. Reaction 
mixtures, without RNA, were used as negative controls 
in each run. Absence of genomic DNA contamination 
was confirmed by setting up control reactions that do 
not contain reverse transcriptase. Fold changes in the 




All data are expressed as means ± SEM. After, 
evaluation of normality using Shapiro-Wilk test, statistical 
differences among the different groups were measured 
using either an unpaired Student t test or 1-way analysis 
of variance (ANOVA) when appropriate with Tukeys post-
hoc test. A P value of ≤0.05 was considered statistically 
significant. Statistical analyses were performed using 
Prism software version 5.0a (GraphPad, San Diego, CA). 
Asterisks in the figures represent the following: *: P ≤0.05; 
**: P ≤ 0.01; and ***: P ≤ 0.001.
Abbreviations
8-oxoG: 7,8-dihydro-8-oxoguanine; CVD: 
Cardiovascular disease; HFD: High fat diet; HSD: High 
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interleukins; NLRP3: NOD-like receptor family, pyrin 
domain containing 3; OGG-1: 8-oxoguanine glycosylase.
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